Using health-related quality of life measures to predict cardiac function in survivors exposed to anthracyclines

Journal of Clinical Oncology

Volumn 22, Issue 15, 2004, Pages 3149-3155

  Ginsberg, Jill P ^a   Cnaan, Avital ^a   Zhao, Huaqing ^a   Clark, Bernard J ^a   Paridon, Stephen M ^a   Chin, Alvin J ^a   Rychik, Jack ^a   Hogarty, Alexa N ^a   Barber, Gerald ^a   Rutkowski, Monika ^a   Kimball, Thomas R ^a   DeLaat, Cynthia ^a   Steinherz, Laurel J ^a   Silber, Jeffrey H ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE;

ARTICLE; CANCER; CANCER SURVIVAL; ECHOCARDIOGRAPHY; FEMALE; HEART FUNCTION; HEART LEFT VENTRICLE PERFORMANCE; HEART OUTPUT; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SHORT FORM 36; ADOLESCENT; ADULT; CHILD; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; HEART; HEART FUNCTION TEST; INFANT; NEOPLASM; PHYSIOLOGY; PREDICTION AND FORECASTING; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; SURVIVOR;

ADOLESCENT; ADULT; ANTHRACYCLINES; CHILD; CHILD, PRESCHOOL; DOUBLE-BLIND METHOD; ECHOCARDIOGRAPHY; FEMALE; HEART; HEART FUNCTION TESTS; HUMANS; INFANT; MALE; NEOPLASMS; PREDICTIVE VALUE OF TESTS; QUALITY OF LIFE; SURVIVORS;

EID: 4143126796     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2004.01.047     Document Type: Article

References (25)

1. Bleyer WA: The impact of childhood cancer on the United States and the world. CA Cancer J Clin 40:355-367, 1990
2. Steinherz LJ, Steinherz PG, Tan CT, et al: Cardiac toxicity 4 to 20 years after completing anthracycline therapy. JAMA 266:1672-1677, 1991
3. Lipshultz SE, Colan SD, Gelber RD, et al: Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. N Engl J Med 324:808-815, 1991
4. Silber JH, Jakacki RI, Larsen RL, et al: Increased risk of cardiac dysfunction after anthracyclines in girls. Med Pediatr Oncol 21:477-479, 1993
5. Krischer JP, Epstein S, Cuthbertson DD, et al: Clinical cardiotoxicity following anthracycline treatment for childhood cancer: The Pediatric Oncology Group experience. J Clin Oncol 15:1544-1552, 1997
6. Lipshultz SE, Lipsitz SR, Mone SM, et al: Female sex and drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer. N Engl J Med 332:1738-1743, 1995
7. Steinherz LJ, Graham T, Hurwitz R, et al: Guidelines for cardiac monitoring of children during and after anthracycline therapy: Report of the Cardiology Committee of the Childrens Cancer Study Group. Pediatrics 89:942-949, 1992
8. Silber JH, Cnaan A, Clark BJ, et al: Design and baseline characteristics for the ACE Inhibitor After Anthracycline (AAA) study of cardiac dysfunction in long-term pediatric cancer survivors. Am Heart J 142:577-585, 2001
9. Silber JH, Cnaan A, Clark BJ, et al: Enalapril to prevent cardiac function decline in long-term survivors of pediatric cancer exposed to anthracyclines. J Clin Oncol 22:820-828, 2004
10. Wasserman K, Hansen J, Sue D: Protocols for exercise testing, in Wasserman K (ed): Principles of Exercise Testing and Interpretation. Philadelphia, PA, Lea & Febiger, 1994, pp 95-111
11. Paridon SM: Exercise testing, in Garson A, Bricker JT, Fisher D, et al (eds): The Science and Practice of Pediatric Cardiology. Baltimore, MD, Williams & Wilkins, 1998, pp 875-888
12. Colan SD, Borow KM, Neumann A: Left ventricular end-systolic wall stress-velocity of fiber shortening relation: A load-independent index of myocardial contractility. J Am Coll Cardiol 4:715-724, 1984
13. Colan SD, Parness IA, Spevak PJ, et al: Developmental modulation of myocardial mechanics: Age- and growth-related alterations in afterload and contractility. J Am Coll Cardiol 19:619-629, 1992
14. Vargo TA: Cardiac catheterization-hemodynamic measurements, in Garson AJ, Bricker JT, McNamara DG (eds): The Science and Practice of Pediatric Cardiology. Philadelphia, PA, Lea & Febiger, 1990
15. Ware JE, Snow KK, Kosinski M, et al: SF-36 Health Survey Manual and Interpretation Guide. Lincoln, RI, QualityMetric Inc, 2000
16. Landgraf JM, Abetz L, Ware JE: The CHQ User's Manual. (second printing). Boston, MA, HealthAct, 1999, pp 27-38
17. Laird NM, Ware JH: Random effects models for longitudinal data. Biometrics 38:963-974, 1982
18. Lipsitz SR, Leong T, Ibrahim J, et al: A partial correlation coefficient and coefficient of determination for multivariate normal repeated measures data. Statistician 50:87-95, 2001
19. Dixon W, Massey F: Introduction to Statistical Analysis (ed 4). New York, NY, McGraw-Hill, 1983, p 224
20. Permanyer-Miralda G, Alonso J, Anto JM, et al: Comparison of perceived health status and conventional functional evaluation in stable patients with coronary artery disease. J Clin Epidemiol 44:779-786, 1991
21. Rumsfeld JS, MaWhinney S, McCarthy M, et al: Health-related quality of life as a predictor of mortality following coronary artery bypass graft surgery. JAMA 281:1298-1303, 1999
22. Krumholz HM, McHorney CA, Clark L, et al: Changes in health after elective percutaneous coronary revascularization: A comparison of generic and specific measures. Med Care 34:754-759, 1996
23. Tsukino M, Nishimura K, Ikeda A, et al: Physiologic factors that determine the health-related quality of life in patients with COPD. Chest 110:896-903, 1996
24. Mitani H, Hashimoto H, Isshiki T, et al: Health-related quality of life of Japanese patients with chronic heart failure. Circ J 67:215-220, 2003
25. Barber G, Heise CT: Subjective estimates of exercise ability: Comparison to objective measurements. Ped Exerc Sci 3:327-332, 1991